Moderna Announces mRNA-1345 Phase 3 Results financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
Potential messenger RNA vaccine showed almost 84% efficacy and was well tolerated Moderna, which developed one of the first messenger RNA vaccines against Covid-19, unveiled positive preliminary results on Tuesday for a trial of respiratory syncytial virus (RSV), which causes bronchiolitis, in the elderly. This phase 3 trial is being conducted double-blind on 37,000 people aged 60 and over in 22 countries, including the United States. According to interim data, the potential m